Today: 21 May 2026
Tesco PLC stock dips ahead of Q3 Christmas update — what TSCO.L investors watch next
7 January 2026
1 min read

Tesco PLC stock dips ahead of Q3 Christmas update — what TSCO.L investors watch next

London, Jan 7, 2026, 09:15 GMT — Regular session

Tesco PLC shares slipped in early trade on Wednesday as investors waited for the grocer’s Q3 and Christmas sales update. The stock (TSCO.L) was down 0.8% at 451.5 pence by 0900 GMT and has traded between 450.5p and 456.2p so far.

Thursday’s trading statement is the first Tesco readout on the holiday quarter, a crucial stretch when UK grocers lean on promotions to defend volumes and market share. Tesco last guided for full-year 2025/26 adjusted operating profit — a measure that strips out some one-off items — of 2.9 billion to 3.1 billion pounds, and Chief Executive Ken Murphy warned that “competitive intensity remains high.” Investegate

Industry data this week put Tesco in a firmer position going into the update. Market researcher Worldpanel by Numerator said Tesco sales rose 4.3% in the 12 weeks to Dec. 28, lifting its market share by 0.2 percentage points to 28.7%, the highest since March 2015, while UK grocery inflation eased to 4.3% in December.

Tesco rose 2.8% on Tuesday to close at 4.55 pounds, outperforming the broader market as the FTSE 100 ended up 1.18%. The shares finished 5.39% below their 52-week high of 4.81 pounds set on Nov. 11, MarketWatch data showed.

The group has also kept up its share buyback — a way to return cash to investors by reducing the number of shares in issue. A filing showed Tesco bought 454,043 shares on Jan. 5 at an average 440.49 pence as part of its 1.45 billion-pound programme, with the stock due to be cancelled.

Chart watchers point to nearby levels after the recent run-up. Axel Rudolph, a senior technical analyst at IG, wrote that a break below 435.5p-433.5p would risk a move toward 431.7p-428.2p, while resistance sits in the 456.6p-458.9p area and then the November peak at 480.9p.

But the update carries a clear risk: if Tesco signals it had to spend more on price cuts than investors expect, or if volumes held up only with heavier discounting, margin worries would return quickly. A softer consumer backdrop would sharpen that focus.

Stock Market Today

  • SpaceX IPO Filing Reveals Financials, Musk Could Become First Trillionaire
    May 20, 2026, 7:08 PM EDT. SpaceX filed for an initial public offering (IPO), disclosing its finances and board members for the first time. The company reported $18.7 billion in revenue for 2025, up 33% year-on-year, but posted a net loss of $4.9 billion, reversing a $791 million profit in 2024. First-quarter 2026 losses reached $4.3 billion on $4.7 billion revenue. The IPO, trading as SPCX, may become the largest ever, potentially boosting Elon Musk's wealth to trillionaire status. SpaceX aims to fund its ambitious plans including Starlink satellite network expansion, AI infrastructure, and establishing extraterrestrial colonies.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says
Previous Story

Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings
Next Story

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

Go toTop